Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post -Marketing Drug Evaluation(Phase IV Clinical Trial) to Study the Safety and Efficacy of Heweizhixie Capsule in Patients With Diarrhea

NCT02607176 is registered in ClinicalTrials.gov with Shanghai University of Traditional Chinese Medicine as lead sponsor.

NCT NCT02607176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02607176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post -Marketing Drug Evaluation(Phase IV Clinical Trial) to Study the Safety and Efficacy of Heweizhixie Capsule in Patients With Diarrhea
Lead sponsor
Shanghai University of Traditional Chinese Medicine
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2015
Completion date
April 30, 2018
Enrollment
2,400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea